Nitric Oxide Consumption as a Predictor of Vasospasm in Subarachnoid Hemorrhage
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorMassachusetts General Hospital
The goal of this observational study is to understand if angiographic cerebral vasospasm (CV) can be predicted by levels of nitric oxide (NO) consumption in patients with aneurysmal subarachnoid hemorrhage (SAH). To reach this goal, the investigators will compare NO consumption levels in SAH and non-SAH patients. NO consumption levels will be analyzed from samples of participants' cerebral spinal fluid (CSF).
Adult
patient with SAH and with an external ventricular drainage (EVD) placed within 24 hours after the onset of the hemorrhage
pregnancy
pre-existing neurological comorbidities
coagulation disorders
anemia
Massachusetts General Hospital
Lead sponsor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS
Collaborator